Skip to main content
logo
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
455.00
+13.55 (3.07%)
Last updated: Oct 1, 2025, 9:15 AM IST

NSE:AKUMS Revenue

Akums Drugs and Pharmaceuticals had revenue of 10.24B INR in the quarter ending June 30, 2025, with 0.48% growth. This brings the company's revenue in the last twelve months to 41.26B, down -2.48% year-over-year. In the fiscal year ending March 31, 2025, Akums Drugs and Pharmaceuticals had annual revenue of 41.21B, down -1.45%.

Revenue (ttm)
41.26B
Revenue Growth
-2.48%
P/S Ratio
1.67
Revenue / Employee
5.48M
Employees
7,536
Market Cap
69.09B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202541.21B-605.31M-1.45%
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 202127.26B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories96.52B
Cipla274.80B
Apollo Hospitals Enterprise225.51B
Mankind Pharma129.10B
Zydus Lifesciences236.08B
Fortis Healthcare80.94B
Alkem Laboratories133.04B
Revenue Rankings

Akums Drugs and Pharmaceuticals News

More News